Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Topic
Download App
简
繁
简
繁
EN
Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Topic
HOME
·
Clinical Trial
Sirnaomics-B (02257.HK): First Patient Dosed in Phase 2 Clinical Trial of STP705 for Medical Aesthetics
Tags:
SIRNAOMICS-B
02257.HK
Medical Aesthetics
Clinical Trial
2026-07-30
Henlius (02696.HK): First Patient Dosed in Phase 1 Trial of Trispecific Antibody HLX3902 Targeting STEAP1×CD3×CD28
Tags:
HENLIUS
02696.HK
Clinical Trial
2026-07-30
KEYMED BIO-B (02162.HK): Global Phase III Trial of CMG901 (AZD0901) Meets Primary Endpoint, Delivers Improved OS for 2L+ Gastric Cancer; AstraZeneca Forecasts Peak Sales of USD3-5 Billion
Tags:
KEYMED BIO-B
02162.HK
AstraZeneca
Clinical Trial
2026-07-28
LEPU BIO (02157.HK): Global Phase III Trial of CMG901 Meets Primary Endpoint, Significantly Improves Overall Survival of CLDN18.2-positive Advanced Gastric Cancer Patients
Tags:
LEPU BIO
02157.HK
AstraZeneca
Clinical Trial
2026-07-28
INNOCARE (09969.HK): Phase III Trial of Fadeucravacitinib (ICP-488) for Moderate to Severe Plaque Psoriasis Meets Primary Endpoint
Tags:
INNOCARE
09969.HK
Clinical Trial
primary endpoint
2026-07-27
SBP GROUP (01177.HK): IM-101 Injection (PreS1 Recombinant Fusion Protein) Obtains NMPA Clinical Trial Approval for Chronic Hepatitis B
Tags:
SBP GROUP
01177.HK
Clinical Trial
2026-07-23
ORBUSNEICH (06929.HK): First Patient Enrolled in Pivotal Japanese Clinical Trial for Self-developed Drug-Coated Balloon
Tags:
ORBUSNEICH
06929.HK
Clinical Trial
2026-07-22
JACOBIO-B (01167.HK): Pan-KRAS Inhibitor JAB-23E73 in Combination with Chemotherapy Completes First Patient Dosing in China for Phase Ib/III First-Line Treatment of KRAS-Mutant Pancreatic Cancer
Tags:
JACOBIO-B
01167.HK
Clinical Trial
2026-07-20
INNOCARE (09969.HK): TYK2 Inhibitor Soficitinib (ICP-332) Meets Primary Endpoint in Phase II for Non-Segmental Vitiligo, 24-Week F-VASI Reduced by Around 39%-41% vs Baseline
Tags:
INNOCARE
09969.HK
Clinical Trial
2026-07-16
HENLIUS (02696.HK): Biosimilar HLX18 to Nivolumab Doses First Patient in China for Global Multi-centre Phase I Trial
Tags:
HENLIUS
02696.HK
Clinical Trial
2026-07-16
JENSCARE-B (09877.HK): LuX-Valve Plus Completes First Implantations in FDA US Pivotal Trial
Tags:
JENSCARE-B
09877.HK
Clinical Trial
2026-07-16
ABBISKO-B (02256.HK): Oral Pan-KRAS Inhibitor ABSK211 Cleared by FDA for Phase I Trial in KRAS-Altered Solid Tumours
Tags:
ABBISKO-B
02256.HK
Clinical Trial
2026-07-13
LONGBIO-B (01779.HK): Anti-IgE Antibody LP-003 Receives FDA Clinical Trial Clearance for Peanut Allergy
Tags:
LongBio-B
01779.HK
Clinical Trial
2026-07-13
HENLIUS (02696.HK): NMPA Approves Phase I Trial for HLX37 (PD-L1/VEGF Bispecific) Plus Chemotherapy or HLX43 (PD-L1 ADC) in Solid Tumours
Tags:
HENLIUS
02696.HK
Clinical Trial
2026-07-10
Shaanxi Micot Pharmaceutical Technology Co., Ltd (02335.HK): Phase II Clinical Study of Dual-Function Antithrombotic Candidate MT1002 for Anticoagulation in Haemodialysis Completes First Patient Enrolment
Tags:
Micot Pharma
02335.HK
Clinical Trial
2026-07-09
HAIXI PHARMA(02637.HK): Phase III Clinical Trial of C019199 Tablets for Osteosarcoma Initiated
Tags:
HAIXI PHARMA
02637.HK
Clinical Trial
2026-07-09
HENLIUS(02696.HK): First Patient Dosed in Phase I Clinical Trial of HLX05-N, a Cetuximab Biosimilar, for Metastatic Colorectal Cancer
Tags:
HENLIUS
02696.HK
Clinical Trial
2026-07-08
INSILICO(03696.HK): Phase III Clinical Trial of Rentosertib for Idiopathic Pulmonary Fibrosis Officially Launched
Tags:
Insilico
03696.HK
Clinical Trial
2026-07-08
Mabwell-B(02493.HK): IND Application of 9MW5211 Injection for Type 1 Diabetes Mellitus Accepted by NMPA
Tags:
MABWELL-B
02493.HK
Clinical Trial
2026-07-07
CSPC PHARMA(01093.HK): Phase II Clinical Trial of SYH2070 Injection for Mixed Hyperlipidaemia Initiated at First Clinical Site in China
Tags:
CSPC PHARMA
01093.HK
Clinical Trial
2026-07-07
Previous
1
2
3
4
5
Next
Finance
METIS TECHBIO-P (07666.HK): plans H-share buyback of up to HKD 300m
Finance
HENGRUI PHARMA (01276.HK): hetrombopag NDA accepted in China
Research
HK Stock Connect Daily: NETEASE -17.60% on Gaming Slump - 20261120
Finance
WATER OASIS GP (01161.HK): FY profit seen doubling to HKD 165-175m
Research
HK AI Concept Stock Daily: BABA-W +3.48% Defies Slump - 20261120
Research
Hong Kong Recently Listed Stocks Daily Report: BRAINAURORA-B Rises 39.50% to Lead; Intelligent Driving and Smart Parking Gain Traction-20261120
Finance
NewTimeSpace | HK Close: HSI -1.89%, Semis and Hardware Lead Declines
Research
HK shares ETFs Daily Report: Fubon Taiwan Semiconductor ETF Falls 9.81% as CSI 300 and India Themes Rise-Nov 20, 2026
Research
Offshore Trust Insight | NIO-SW (09866.HK) -5.07%; Users Trust 50m
Research
HK Stock Connect Insight | RA MATERIALS (09607.HK) -13.26%; Stake Rise
Scan QR Code
Download App